The demographic characteristics of participants and their responses to questions about mild hemoptysis in ambulatory outpatients and life-threatening hemoptysis in critically ill individuals were recorded. Responses were entered on as many as 118 keypads, with a mean±SD of 104 ±9.1 responses per question. Seventy-nine individuals responded to over 80 percent of questions. Data from all respondents are reported. When analysis was limited solely to those who answered more than 80 percent of questions, the relative distributions of answers were similar to those of the entire group.
Characteristics of participants are summarized in Table 1. They were predominantly pulmonologists (66 percent), with a smaller number of intensivists and thoracic surgeons. Although their clinical practices were located in diverse settings, most (72 percent) were based in community hospitals. A wide spectrum of experience was represented, ranging from physicians in fellowship training to those in practice for >20 years. Participants commonly assessed patients with hemoptysis: 42 percent of them evaluated more than 20 patients annually with nonmassive bleeding. Massive pulmonary hemorrhage (defined at this session by a bleeding rate exceeding 400 to 600 ml during a 16- to 24-hour period) were encountered much less often, with most evaluating such patients per year.
eriacta 100 mg
Table 1—Characteristics of Physicians
Primary specialty orientation (n* = 96)
Setting of practice (n* = 89)
Academician, university based practice
University-affiliated community hospital
Level of experience (n* = 99)
Years of Practice
Number of patients with hemoptysis seen
annually (n* = 107)
Number of patients with massive hemoptysis seen
annually (n* = 103)
Responses of the following groups were compared: pulmonologists vs other specialists, academicians vs community hospital practitioners, individuals with >10 years of practice vs those having >10 years experience, respondents caring for <=20 patients annually with hemoptysis vs those evaluating >20 per year, and physicians managing patients with massive hemoptysis per year vs those with >5 such patients each year. Unless otherwise indicated, all of these groups had similar patterns of responses to questions about patient management.